Position in LH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,960,518
+$1,872,563 QoQ
Shares Held
11,096
+192.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Empowered Funds, LLC holds $69,341,403 across 20 Diagnostics & Research names. LH ranks #8 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
32,436 | $15,943,260 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
25,730 | $12,355,284 | |
| 3 | DHR |
Danaher Corp /De/
|
49,650 | $9,413,637 | |
| 4 | A |
Agilent Technologies, Inc.
|
35,914 | $4,093,475 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
2,722 | $3,432,982 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
19,519 | $3,328,767 | |
| 7 | CSTL |
Castle Biosciences Inc
|
132,184 | $3,245,117 | |
| 8 | LH |
Labcorp Holdings Inc.
This page
|
11,096 | $2,960,518 |
All Filings in LH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,960,518 | 11,096 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $1,087,955 | 3,790 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $2,166,756 | 8,254 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $1,777,667 | 7,638 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $1,840,292 | 8,025 | Shares | Other | 2025-01-28 | |
| 2024-09-30 | $1,783,817 | 7,982 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $1,500,681 | 7,374 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||